智通财经APP讯，卓正医疗(02677)发布公告，招股章程所述的超额配股权已于2026年3月5日由联席保荐人兼整体协调人(为其本身及代表国际包销商)部分行使，涉及合共19.61万股股份，占任何超额配股权获行使前全球发售项下可供认购的发售股份总数约4.13%。公司将以每股59.90港元发行及配发超额配发股份。超额配发股份将用于促进向已同意延迟交付其根据全球发售认购的相关发售股份的投资者交付部分股份。此外，与全球发售相关的稳定价格期已于2026年3月5日结束。
智通财经APP讯，卓正医疗(02677)发布公告，招股章程所述的超额配股权已于2026年3月5日由联席保荐人兼整体协调人(为其本身及代表国际包销商)部分行使，涉及合共19.61万股股份，占任何超额配股权获行使前全球发售项下可供认购的发售股份总数约4.13%。公司将以每股59.90港元发行及配发超额配发股份。超额配发股份将用于促进向已同意延迟交付其根据全球发售认购的相关发售股份的投资者交付部分股份。此外，与全球发售相关的稳定价格期已于2026年3月5日结束。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.